Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hepatotoxicity of methotrexate in the treatment of psoriasis.

× No keyword cloud information.

11 in total

1. A prospective analysis of liver biopsies in rheumatoid arthritis patients receiving long term methotrexate therapy.

Authors: M Tishler; D Caspi; Z Halperin; M Baratz; M Moshkowitz; M Yaron
Journal: Rheumatol Int Date: 1992 Impact factor: 2.631

Review 2. Research into psoriasis--the last decade.

Authors: S Shuster
Journal: Br Med J Date: 1971-07-24

3. Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis.

Authors: R F Willkens; P A Leonard; D O Clegg; K G Tolman; J R Ward; C R Marks; M L Greene; G J Roth; C G Jackson; G W Cannon
Journal: Ann Rheum Dis Date: 1990-08 Impact factor: 19.103

Review 4. Hepatotoxicity of methotrexate in rheumatic diseases.

Authors: S Kevat; M Ahern; P Hall
Journal: Med Toxicol Adverse Drug Exp Date: 1988 May-Jun

5. Methotrexate and hepatic toxicity in rheumatoid arthritis and psoriatic arthritis.

Authors: Lindsey Tilling; Sue Townsend; Joel David
Journal: Clin Drug Investig Date: 2006 Impact factor: 2.859

Review 6. [Quality and quantity in hepatopathology. Diagnostic and clinically relevant grading for non-tumourous liver diseases].

Authors: T Longerich; C Flechtenmacher; P Schirmacher
Journal: Pathologe Date: 2008-02 Impact factor: 1.011

10. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.

Authors: S B Lanse; G L Arnold; J D Gowans; M M Kaplan
Journal: Dig Dis Sci Date: 1985-02 Impact factor: 3.199

Hepatotoxicity of methotrexate in the treatment of psoriasis.